Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr;11(4):429-430.
doi: 10.1002/mdc3.13968. Epub 2024 Jan 21.

Amantadine Responsive Methcathinone (Ephedrone) Induced Parkinsonism

Avner Thaler  1   2   3   4 , Tanya Gurevich  1   2   4
Affiliations

Amantadine Responsive Methcathinone (Ephedrone) Induced Parkinsonism

Avner Thaler et al. Mov Disord Clin Pract. 2024 Apr.
No abstract available

Keywords: amantadine; drug induced parkinsonism; methcathione.

PubMed Disclaimer

References

    1. Sikk K, Taba P, Haldre S, et al. Irreversible motor impairment in young addicts? Ephedrone, manganism or both? Acta Neurol Scand 2007;115(6):385–389. - PubMed
    1. Stepens A, Logina I, Liguts V, et al. A parkinsonian syndrome in methcathinone users and the role of manganese. N Engl J Med 2008;358(10):1009–1017. - PubMed
    1. Sikk K, Haldre S, Aquilonius SM, et al. Manganese‐induced parkinsonism in methcathinone abusers: bio‐markers of exposure and follow‐up. Eur J Neurol 2013;20(6):915–920. - PubMed
    1. Blanpied TA, Clarke RJ, Johnson JW. Amantadine inhibits NMDA receptors by accelerating channel closure during channel block. J Neurosci 2005;25(13):3312–3322. - PMC - PubMed
    1. Kestenbaum M, Abu Snineh M, Nussbaum T, et al. Repeated intravenous amantadine infusions in advanced parkinsonism: experience of a large movement disorder center. Isr Med Assoc J 2019;21(12):812–816. - PubMed

LinkOut - more resources